Contribution of 20-HETE to the vasodilator actions of nitric oxide in renal arteries

被引:69
作者
Alonso-Galicia, M
Sun, CW
Falck, JR
Harder, DR
Roman, RJ
机构
[1] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA
[2] Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75235 USA
关键词
cytochrome P-450 enzymes; arachidonic acid; potassium channels; guanosine; 3; 5 '-cyclic monophosphate; renal circulation;
D O I
10.1152/ajprenal.1998.275.3.F370
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
The present study examined the contribution of elevations in cGMP Versus inhibition of cytochrome P-4504A enzymes and the production of the vasoconstrictor 20-hydroxyeicosatetraenoic acid (20-HETE) to the vasodilator actions of NO in renal arterioles. The NO donor sodium nitroprusside (SNP) at 10(-5), 10(-4), and 10(-3) M reduced the production of 20-HETE in microsomes prepared from renal arterioles to 80 +/- 2, 43 +/- 5, and 7 +/- 1% of control, respectively (n = 4). In other experiments, the vasodilator response to SNP (10(-7) to 10(-3) M) was examined in rat renal interlobular arteries (<90 mu m ID), preconstricted with phenylephrine (1 mu M) under control conditions and after blockade of the cGMP and P-4504A pathways. Inhibition of guanylyl cyclase with 1H-[1,2,4]oxadiazole[4,3-a]quinoxalin-1-one (ODQ) (10 mu M, n = 6) or of cGMP-dependent protein kinase with 8R,9S,11S-(-)-9-methoxy-carbamyl-8-methyl-2,3,9,10-tetrahydro-8,11-epoxy-1H,8H,11H-2,7b,11a-trizadibenzo-(a,g)-cycloocta-(c,d,e)-trinden-1-one (KT-5823, 1 mu M; n = 5) attenuated the vasodilator response to SNP by 26 and 30%, respectively. In contrast, inhibition of the endogenous production of 20-HETE with a suicide substrate, irreversible inhibitor [17-octadecynoic acid (17-ODYA), 1 mu M, n = 5], or a selective, competitive inhibitor of 20-HETE formation (di-bromo-dodecenyl-methylsulfimide, 25 mu M, n = 5) markedly impaired the vasodilator response to SNP by 76 and 78%, respectively. Similarly, when 20-HETE levels mere fixed at 100 nM (n = 6), the response to SNP was attenuated by 73%. Blockade of both pathways with ODQ and 17-ODYA completely abolished the response to SNP (n = 6). These results indicate that the vasodilator response to NO is largely cGMP independent and that inhibition of 20-HETE formation contributes to the cGMP-independent effects of NO in the renal microcirculation.
引用
收藏
页码:F370 / F378
页数:9
相关论文
共 31 条
  • [1] Inhibition of 20-HETE production contributes to the vascular responses to nitric oxide
    AlonsoGalicia, M
    Drummond, HA
    Reddy, KK
    Falck, JR
    Roman, RJ
    [J]. HYPERTENSION, 1997, 29 (01) : 320 - 325
  • [2] NITRIC-OXIDE IN THE KIDNEY - SYNTHESIS, LOCALIZATION, AND FUNCTION
    BACHMANN, S
    MUNDEL, P
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1994, 24 (01) : 112 - 129
  • [3] NITRIC-OXIDE DIRECTLY ACTIVATES CALCIUM-DEPENDENT POTASSIUM CHANNELS IN VASCULAR SMOOTH-MUSCLE
    BOLOTINA, VM
    NAJIBI, S
    PALACINO, JJ
    PAGANO, PJ
    COHEN, RA
    [J]. NATURE, 1994, 368 (6474) : 850 - 853
  • [4] Nitrovasodilators relax mesenteric microvessels by cGMP-induced stimulation of Ca-activated K channels
    Carrier, GO
    Fuchs, LC
    Winecoff, AP
    Giulumian, AD
    White, RE
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1997, 273 (01): : H76 - H84
  • [5] ACETYLCHOLINE RELEASES ENDOTHELIUM-DERIVED HYPERPOLARIZING FACTOR AND EDRF FROM RAT-BLOOD VESSELS
    CHEN, G
    SUZUKI, H
    WESTON, AH
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1988, 95 (04) : 1165 - 1174
  • [6] THE ROLE OF NITRIC-OXIDE AND OTHER ENDOTHELIUM-DERIVED VASOACTIVE SUBSTANCES IN VASCULAR-DISEASE
    COHEN, RA
    [J]. PROGRESS IN CARDIOVASCULAR DISEASES, 1995, 38 (02) : 105 - 128
  • [7] ENDOTHELIUM-DEPENDENT HYPERPOLARIZATION - BEYOND NITRIC-OXIDE AND CYCLIC-GMP
    COHEN, RA
    VANHOUTTE, PM
    [J]. CIRCULATION, 1995, 92 (11) : 3337 - 3349
  • [8] 2 MECHANISMS MEDIATE RELAXATION BY BRADYKININ OF PIG CORONARY-ARTERY - NO-DEPENDENT AND NO-INDEPENDENT RESPONSES
    COWAN, CL
    COHEN, RA
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 261 (03): : H830 - H835
  • [9] Feelisch M., 1996, METHODS NITRIC OXIDE, P455
  • [10] Griscavage J M, 1995, Adv Pharmacol, V34, P215